Clinical Trial Update: Meta-analysis of 46 FDA Identified Studies on Lipid Markers

View source ↗

Summary

A meta-analysis of 46 FDA-identified studies on lipid markers summarizes findings relevant to cardiovascular diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: University of Toronto | Conditions: Cardiovascular Diseases | Status: UNKNOWN